Q9H6U8 (ALG9_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
Alpha-1,2-mannosyltransferase ALG9
EC=2.4.1.259
EC=2.4.1.261

Alternative name(s):
Asparagine-linked glycosylation protein 9 homolog
Disrupted in bipolar disorder protein 1
Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase
Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase

Gene names

Name:	ALG9
Synonyms:	DIBD1

Organism

Homo sapiens (Human) [Reference proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

cellular organisms › Eukaryota › Opisthokonta › Metazoa › Eumetazoa › Bilateria › Deuterostomia › Chordata › Craniata › Vertebrata › Gnathostomata › Teleostomi › Euteleostomi › Sarcopterygii › Tetrapoda › Amniota › Mammalia › Theria › Eutheria › Euarchontoglires › Primates › Haplorrhini › Simiiformes › Catarrhini › Hominoidea › Hominidae › Homininae › Homo

Protein attributes

Sequence length	611 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	Catalyzes the transfer of mannose from Dol-P-Man to lipid-linked oligosaccharides. Ref.6 Ref.7
Catalytic activity	Dolichyl beta-D-mannosyl phosphate + D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->3)-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol + dolichyl phosphate. Dolichyl beta-D-mannosyl phosphate + D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->6))-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-[D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->6))-D-Man-alpha-(1->6)]-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol + dolichyl phosphate.
Pathway	Protein modification; protein glycosylation.
Subcellular location	Endoplasmic reticulum membrane; Multi-pass membrane protein Probable.
Tissue specificity	Ubiquitously expressed; with highest levels in heart, liver and pancreas. Ref.1
Involvement in disease	A chromosomal aberration involving ALG9 is found in a family with bipolar affective disorder. Translocation t(9;11)(p24;q23). However, common variations in ALG9 do not play a major role in predisposition to bipolar affective disorder. Congenital disorder of glycosylation 1L (CDG1L) [MIM:608776]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.6 Ref.7
Sequence similarities	Belongs to the glycosyltransferase 22 family.

Ontologies

Keywords
Cellular component	Endoplasmic reticulum Membrane
Coding sequence diversity	Alternative splicing Chromosomal rearrangement Polymorphism
Disease	Congenital disorder of glycosylation Disease mutation
Domain	Transmembrane Transmembrane helix
Molecular function	Glycosyltransferase Transferase
PTM	Glycoprotein
Technical term	Complete proteome Reference proteome
Gene Ontology (GO)
Biological_process	GPI anchor biosynthetic process Inferred from electronic annotation. Source: InterPro dolichol-linked oligosaccharide biosynthetic process Traceable author statement. Source: Reactome post-translational protein modification Traceable author statement. Source: Reactome protein N-linked glycosylation via asparagine Traceable author statement. Source: Reactome
Cellular_component	endoplasmic reticulum membrane Traceable author statement. Source: Reactome integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW intrinsic to endoplasmic reticulum membrane Inferred from electronic annotation. Source: InterPro
Molecular_function	dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity Inferred from electronic annotation. Source: EC dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity Inferred from electronic annotation. Source: EC
Complete GO annotation...

Alternative products

This entry describes 4 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 (identifier: Q9H6U8-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 (identifier: Q9H6U8-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-171: Missing.

Isoform 3 (identifier: Q9H6U8-3)

The sequence of this isoform differs from the canonical sequence as follows:
     391-391: Q → QHSFLYFQ

Isoform 4 (identifier: Q9H6U8-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1-171: Missing.
     391-391: Q → QHSFLYFQ

Note: No experimental confirmation available.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 611	611	Alpha-1,2-mannosyltransferase ALG9		PRO_0000215787
Regions
	Topological domain	1 – 135	135	Lumenal Potential
	Transmembrane	136 – 156	21	Helical; Potential
	Topological domain	157 – 171	15	Cytoplasmic Potential
	Transmembrane	172 – 192	21	Helical; Potential
	Topological domain	193 – 213	21	Lumenal Potential
	Transmembrane	214 – 234	21	Helical; Potential
	Topological domain	235 – 249	15	Cytoplasmic Potential
	Transmembrane	250 – 270	21	Helical; Potential
	Topological domain	271 – 304	34	Lumenal Potential
	Transmembrane	305 – 325	21	Helical; Potential
	Topological domain	326 – 342	17	Cytoplasmic Potential
	Transmembrane	343 – 363	21	Helical; Potential
	Topological domain	364 – 370	7	Lumenal Potential
	Transmembrane	371 – 391	21	Helical; Potential
	Topological domain	392 – 405	14	Cytoplasmic Potential
	Transmembrane	406 – 426	21	Helical; Potential
	Topological domain	427 – 611	185	Lumenal Potential
Sites
	Site	340	1	Breakpoint for translocation
Amino acid modifications
	Glycosylation	77	1	N-linked (GlcNAc...) Potential
	Glycosylation	593	1	N-linked (GlcNAc...) Potential
Natural variations
	Alternative sequence	1 – 171	171	Missing in isoform 2 and isoform 4.		VSP_015434
	Alternative sequence	391	1	Q → QHSFLYFQ in isoform 3 and isoform 4.		VSP_015435
	Natural variant	232	1	A → P. Corresponds to variant rs36111204 [ dbSNP | Ensembl ].		VAR_049221
	Natural variant	255	1	S → L. Corresponds to variant rs17113312 [ dbSNP | Ensembl ].		VAR_049222
	Natural variant	287	1	Y → C in CDG1L; impairs activity. Ref.7		VAR_023410
	Natural variant	289	1	V → I. Ref.1 Ref.4 Ref.6 Corresponds to variant rs10502151 [ dbSNP | Ensembl ].		VAR_023411
	Natural variant	506	1	P → L. Ref.1		VAR_023412
	Natural variant	523	1	E → K in CDG1L; impairs activity. Ref.6		VAR_023413
	Natural variant	528	1	I → S. Corresponds to variant rs12575909 [ dbSNP | Ensembl ].		VAR_049223
Experimental info
	Sequence conflict	309	1	N → K Ref.1
	Sequence conflict	309	1	N → K Ref.2

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 [UniParc]. Last modified August 30, 2005. Version 2. Checksum: 51EC72DDBD866713	FASTA	611	69,863
	10 20 30 40 50 60 MASRGARQRL KGSGASSGDT APAADKLREL LGSREAGGAE HRTELSGNKA GQVWAPEGST 70 80 90 100 110 120 AFKCLLSARL CAALLSNISD CDETFNYWEP THYLIYGEGF QTWEYSPAYA IRSYAYLLLH 130 140 150 160 170 180 AWPAAFHARI LQTNKILVFY FLRCLLAFVS CICELYFYKA VCKKFGLHVS RMMLAFLVLS 190 200 210 220 230 240 TGMFCSSSAF LPSSFCMYTT LIAMTGWYMD KTSIAVLGVA AGAILGWPFS AALGLPIAFD 250 260 270 280 290 300 LLVMKHRWKS FFHWSLMALI LFLVPVVVID SYYYGKLVIA PLNIVLYNVF TPHGPDLYGT 310 320 330 340 350 360 EPWYFYLING FLNFNVAFAL ALLVLPLTSL MEYLLQRFHV QNLGHPYWLT LAPMYIWFII 370 380 390 400 410 420 FFIQPHKEER FLFPVYPLIC LCGAVALSAL QKCYHFVFQR YRLEHYTVTS NWLALGTVFL 430 440 450 460 470 480 FGLLSFSRSV ALFRGYHGPL DLYPEFYRIA TDPTIHTVPE GRPVNVCVGK EWYRFPSSFL 490 500 510 520 530 540 LPDNWQLQFI PSEFRGQLPK PFAEGPLATR IVPTDMNDQN LEEPSRYIDI SKCHYLVDLD 550 560 570 580 590 600 TMRETPREPK YSSNKEEWIS LAYRPFLDAS RSSKLLRAFY VPFLSDQYTV YVNYTILKPR 610 KAKQIRKKSG G
	Isoform 2 [UniParc]. Checksum: 42D3547330EA5EBB	FASTA	440	50,820
	10 20 30 40 50 60 MMLAFLVLST GMFCSSSAFL PSSFCMYTTL IAMTGWYMDK TSIAVLGVAA GAILGWPFSA 70 80 90 100 110 120 ALGLPIAFDL LVMKHRWKSF FHWSLMALIL FLVPVVVIDS YYYGKLVIAP LNIVLYNVFT 130 140 150 160 170 180 PHGPDLYGTE PWYFYLINGF LNFNVAFALA LLVLPLTSLM EYLLQRFHVQ NLGHPYWLTL 190 200 210 220 230 240 APMYIWFIIF FIQPHKEERF LFPVYPLICL CGAVALSALQ KCYHFVFQRY RLEHYTVTSN 250 260 270 280 290 300 WLALGTVFLF GLLSFSRSVA LFRGYHGPLD LYPEFYRIAT DPTIHTVPEG RPVNVCVGKE 310 320 330 340 350 360 WYRFPSSFLL PDNWQLQFIP SEFRGQLPKP FAEGPLATRI VPTDMNDQNL EEPSRYIDIS 370 380 390 400 410 420 KCHYLVDLDT MRETPREPKY SSNKEEWISL AYRPFLDASR SSKLLRAFYV PFLSDQYTVY 430 440 VNYTILKPRK AKQIRKKSGG
	Isoform 3 [UniParc]. Checksum: 05790C3513BF8A4D	FASTA	618	70,786
	10 20 30 40 50 60 MASRGARQRL KGSGASSGDT APAADKLREL LGSREAGGAE HRTELSGNKA GQVWAPEGST 70 80 90 100 110 120 AFKCLLSARL CAALLSNISD CDETFNYWEP THYLIYGEGF QTWEYSPAYA IRSYAYLLLH 130 140 150 160 170 180 AWPAAFHARI LQTNKILVFY FLRCLLAFVS CICELYFYKA VCKKFGLHVS RMMLAFLVLS 190 200 210 220 230 240 TGMFCSSSAF LPSSFCMYTT LIAMTGWYMD KTSIAVLGVA AGAILGWPFS AALGLPIAFD 250 260 270 280 290 300 LLVMKHRWKS FFHWSLMALI LFLVPVVVID SYYYGKLVIA PLNIVLYNVF TPHGPDLYGT 310 320 330 340 350 360 EPWYFYLING FLNFNVAFAL ALLVLPLTSL MEYLLQRFHV QNLGHPYWLT LAPMYIWFII 370 380 390 400 410 420 FFIQPHKEER FLFPVYPLIC LCGAVALSAL QHSFLYFQKC YHFVFQRYRL EHYTVTSNWL 430 440 450 460 470 480 ALGTVFLFGL LSFSRSVALF RGYHGPLDLY PEFYRIATDP TIHTVPEGRP VNVCVGKEWY 490 500 510 520 530 540 RFPSSFLLPD NWQLQFIPSE FRGQLPKPFA EGPLATRIVP TDMNDQNLEE PSRYIDISKC 550 560 570 580 590 600 HYLVDLDTMR ETPREPKYSS NKEEWISLAY RPFLDASRSS KLLRAFYVPF LSDQYTVYVN 610 YTILKPRKAK QIRKKSGG
	Isoform 4 [UniParc]. Checksum: 21DA4AC7B2DE59DE	FASTA	447	51,743
	10 20 30 40 50 60 MMLAFLVLST GMFCSSSAFL PSSFCMYTTL IAMTGWYMDK TSIAVLGVAA GAILGWPFSA 70 80 90 100 110 120 ALGLPIAFDL LVMKHRWKSF FHWSLMALIL FLVPVVVIDS YYYGKLVIAP LNIVLYNVFT 130 140 150 160 170 180 PHGPDLYGTE PWYFYLINGF LNFNVAFALA LLVLPLTSLM EYLLQRFHVQ NLGHPYWLTL 190 200 210 220 230 240 APMYIWFIIF FIQPHKEERF LFPVYPLICL CGAVALSALQ HSFLYFQKCY HFVFQRYRLE 250 260 270 280 290 300 HYTVTSNWLA LGTVFLFGLL SFSRSVALFR GYHGPLDLYP EFYRIATDPT IHTVPEGRPV 310 320 330 340 350 360 NVCVGKEWYR FPSSFLLPDN WQLQFIPSEF RGQLPKPFAE GPLATRIVPT DMNDQNLEEP 370 380 390 400 410 420 SRYIDISKCH YLVDLDTMRE TPREPKYSSN KEEWISLAYR PFLDASRSSK LLRAFYVPFL 430 440 SDQYTVYVNY TILKPRKAKQ IRKKSGG

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family." Baysal B.E., Willett-Brozick J.E., Badner J.A., Corona W., Ferrell R.E., Nimgaonkar V.L., Detera-Wadleigh S.D. Neurogenetics 4:43-53(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION, TISSUE SPECIFICITY, VARIANTS ILE-289 AND LEU-506.
[2]	Guo J.H., Yu L. Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Lymphoma.
[3]	"Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W., Ottenwaelder B., Obermaier B. , Tampe J., Heubner D., Wambutt R., Korn B., Klein M., Poustka A. Genome Res. 11:422-435(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Uterus.
[4]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), VARIANT ILE-289.
[5]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Muscle.
[6]	"Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL." Frank C.G., Grubenmann C.E., Eyaid W., Berger E.G., Aebi M., Hennet T. Am. J. Hum. Genet. 75:146-150(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, VARIANT CDG1L LYS-523, VARIANT ILE-289.
[7]	"CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features." Weinstein M., Schollen E., Matthijs G., Neupert C., Hennet T., Grubenmann C.E., Frank C.G., Aebi M., Clarke J.T.R., Griffiths A., Seargeant L., Poplawski N. Am. J. Med. Genet. A 136:194-197(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, VARIANT CDG1L CYS-287.
[8]	"Common variations in ALG9 are not associated with bipolar I disorder: a family-based study." Baysal B.E., Willett-Brozick J.E., Bacanu S.A., Detera-Wadleigh S., Nimgaonkar V.L. Behav. Brain Funct. 2:25-25(2006) [PubMed] [Europe PMC] [Abstract] Cited for: LACK OF ASSOCIATION WITH BIPOLAR AFFECTIVE DISORDERS.
+	Additional computationally mapped references.

Web resources

GGDB

GlycoGene database

GeneReviews

Cross-references

Sequence databases
EMBL GenBank DDBJ	AF395532 mRNA. Translation: AAL25798.1. AF454937 mRNA. Translation: AAP97696.1. AL136927 mRNA. Translation: CAB66861.1. AK025498 mRNA. Translation: BAB15154.1. AK172828 mRNA. Translation: BAD18793.1. BC009255 mRNA. Translation: AAH09255.1.
IPI	IPI00234857. IPI00642390. IPI00645383. IPI00983792.
RefSeq	NP_001071158.1. NM_001077690.1. NP_001071159.1. NM_001077691.1. NP_001071160.1. NM_001077692.1. NP_079016.2. NM_024740.2.
UniGene	Hs.503850.
3D structure databases
ProteinModelPortal	Q9H6U8.
ModBase	Search...
Protein-protein interaction databases
IntAct	Q9H6U8. 2 interactions.
Protein family/group databases
CAZy	GT22. Glycosyltransferase Family 22.
PTM databases
PhosphoSite	Q9H6U8.
Polymorphism databases
DMDM	73921666.
Proteomic databases
PaxDb	Q9H6U8.
PRIDE	Q9H6U8.
Protocols and materials databases
DNASU	79796.
StructuralBiologyKnowledgebase	Search...
Genome annotation databases
Ensembl	ENST00000398006; ENSP00000381090; ENSG00000086848. ENST00000531154; ENSP00000435517; ENSG00000086848. ENST00000585430; ENSP00000468731; ENSG00000262577. ENST00000586097; ENSP00000466066; ENSG00000262577. ENST00000587827; ENSP00000465238; ENSG00000262577. ENST00000592795; ENSP00000467759; ENSG00000262577.
GeneID	79796.
KEGG	hsa:79796.
UCSC	uc001ply.3. human. uc001plz.3. human. uc021qqm.1. human.
Organism-specific databases
CTD	79796.
GeneCards	GC11M111652.
HGNC	HGNC:15672. ALG9.
HPA	HPA038575.
MIM	606941. gene. 608776. phenotype.
neXtProt	NX_Q9H6U8.
Orphanet	79328. CDG syndrome type IL.
PharmGKB	PA134887582.
GenAtlas	Search...
Phylogenomic databases
eggNOG	COG0072.
HOVERGEN	HBG062906.
InParanoid	Q9H6U8.
KO	K03846.
OrthoDB	EOG4GB75G.
Enzyme and pathway databases
Reactome	REACT_17015. Metabolism of proteins.
UniPathway	UPA00378.
Gene expression databases
Bgee	Q9H6U8.
CleanEx	HS_ALG9.
Genevestigator	Q9H6U8.
GermOnline	ENSG00000086848. Homo sapiens.
Family and domain databases
InterPro	IPR005599. GPI_mannosylTrfase. [Graphical view]
PANTHER	PTHR22760. PTHR22760. 1 hit.
Pfam	PF03901. Glyco_transf_22. 1 hit. [Graphical view]
ProtoNet	Search...
Other
GenomeRNAi	79796.
NextBio	69332.
SOURCE	Search...

Entry information

Entry name

ALG9_HUMAN

Accession

Primary (citable) accession number: Q9H6U8
Secondary accession number(s): Q6ZMD5 , Q7Z4R4, Q96GS7, Q96PB9, Q9H068

Entry history

Integrated into UniProtKB/Swiss-Prot:	August 30, 2005
Last sequence update:	August 30, 2005
Last modified:	May 1, 2013
This is version 95 of the entry and version 2 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.